Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

5.27
Data as of Sep 12
 -0.15 / -2.77%
Today’s Change
3.10
Today|||52-Week Range
7.45
-1.13%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$366.6M

Company Description

PProgenics Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases. Its pipeline candidates include PSMA ADC, a fully human monoclonal antibody-drug conjugate (ADC) directed toward PSMA and designed to deliver targeted chemotherapy to cancer cells, and MIP-1404, an imaging agent candidate with potential to alter clinical practice in treating prostate cancer. Its principal programs are directed toward gastroenterology, oncology and virology. Progenics Pharmaceuticals was founded by Paul J. Maddon on December 1, 1986 and is headquartered in Tarrytown, NY.

Contact Information

Progenics Pharmaceuticals, Inc.
777 Old Saw Mill River Road
Tarrytown New York 10591
P:(914) 789-2800
Investor Relations:

Employees

Shareholders

Other institutional39.23%
Mutual fund holders37.76%
Individual stakeholders15.26%

Top Executives

Mark Robert BakerPresident, Chief Executive Officer & Director
Angelo William LovalloChief Financial Officer, Treasurer, CAO & VP
Robert J. IsraelExecutive Vice President-Medical Affairs
Hagop YoussoufianExecutive Vice President-Research & Development
John W. BabichSenior Vice President

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.